Skip to main navigation

About
- Company
- Leadership
- Laboratory
- Careers
Products
Applications
- Personalized Cancer Vaccines
- Biomarker Discovery
Technology
Resources
- What’s New
- Conferences
- Library
- Blog
- Contact
Investors

Press Releases

Press Releases

Year

Sep 12, 2019

Personalis Appoints Karin Eastham to Its Board of Directors

Sep 09, 2019

Personalis, Inc. Enters Into Research Agreement With Invectys to Provide Comprehensive Tumor Immunogenomics Profiling for Clinical Trial

Aug 26, 2019

Personalis to Participate in the 17th Annual Morgan Stanley Global Healthcare Conference

Aug 13, 2019

Personalis Reports Second Quarter 2019 Financial Results

Aug 07, 2019

Personalis, Inc. to Provide Comprehensive Tumor Immunogenomic Profiling to the New Mexico Cancer Care Alliance for Clinical Study

Aug 01, 2019

Personalis, Inc. Announces Integration of New ImmunoID NeXT Platform™ Features in Latest Expansion of Immuno-Oncology Biomarker Discovery Applications

Jul 30, 2019

Personalis to Announce Second Quarter 2019 Financial Results on August 13, 2019

Jun 24, 2019

Personalis Announces Closing of Initial Public Offering and Exercise in Full of Over Allotment Option

Jun 19, 2019

Personalis Prices Initial Public Offering of Common Stock

May 22, 2019

Personalis, Inc. to Provide Tumor Immunogenomic Profiling to the Parker Institute for Immunotherapy Biomarker Discovery in Clinical Trial Participants

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 19

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website

© 2019 Personalis Inc. All rights reserved.